102 results
424B5
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Prospectus supplement for primary offering
4:02pm
thereof. It may determine the amount of such consideration by approving a formula. In the absence of actual fraud in the transaction, the judgment … to relate to a penal, revenue or other public law);
the judgment was not procured by fraud;
recognition or enforcement of the judgment in England
8-K
EX-5.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
to promote the success of the Company), and there has not been and will not be any bad faith, breach of trust, fraud, coercion, duress or undue influence
8-K
EX-1.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
to health care fraud and abuse, including but not limited to the U.S. False Statements Law (42 U.S.C. Section 1320a-7b(a)), 18 U.S.C. Sections 286 and 287 … , and the health care fraud criminal provisions under HIPAA (42 U.S.C. Section 1320d et seq.), the U.S. Physician Payments Sunshine Act (42 U.S.C
424B5
9g8ni
11 Sep 24
Prospectus supplement for primary offering
4:40pm
S-3ASR
9lun0kk30
11 Sep 24
Automatic shelf registration
4:01pm
S-3ASR
EX-5.1
mb02e kn7o
11 Sep 24
Automatic shelf registration
4:01pm
DEFA14A
1el6408xh
20 May 24
Additional proxy soliciting materials
8:48pm
424B5
96zgpq soxz
24 Apr 24
Prospectus supplement for primary offering
8:53pm
8-K
EX-5.1
h13830yvfoa9d
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
8-K
EX-1.1
mli0792sbj7
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
424B5
n1cj02
23 Apr 24
Prospectus supplement for primary offering
5:16pm